Author: Martin P.R. Adinoff B. Lane E. Stapleton J.M. Bone G.A.H. Weingartner H. Linnoila M. Eckardt M.J.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.5, Iss.1, 1995-03, pp. : 27-33
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fluvoxamine improves affect lability in borderline personality disorder
Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. :
The treatment of dysthymic patients: fluvoxamine versus amitriptyline
By Amore M. Ricci M. Zazzeri N.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France
By Nuijten M.
PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. :